LUMID

Live / Registered — Registered (as of 18 Nov 2025)

What this means for you

Registered since 18 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97602709
Registration number
8033148
Mark type
Stylized text
Filed
22 Sept 2022
Published for opposition
21 May 2024
Registered
18 Nov 2025
Attorney of record
Ian W. Gillies

Goods and services

  • Class 042 — Scientific and technological services: Pharmaceutical drug discovery services; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, and biotechnology; consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, and biotechnology; research and development of new products; providing scientific information, scientific, pharmaceutical, and medical research in the field of developing pharmaceutical drugs, drug discovery and development services, and consulting services with respect to using a photocatalyst molecule for labeling a protein proximate to a target disease-causing protein within a live cell

Owner

Prosecution history

  • 18 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 18 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
  • 28 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 28 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 15 Oct 2025 — STATEMENT OF USE PROCESSING COMPLETE
  • 16 Jan 2025 — USE AMENDMENT FILED
  • 29 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 28 Apr 2025 — SOU EXTENSION 1 GRANTED
  • 16 Jan 2025 — SOU EXTENSION 1 FILED
  • 17 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 16 Jan 2025 — SOU TEAS EXTENSION RECEIVED
  • 06 Nov 2024 — TEAS STATEMENT OF USE RECEIVED
  • 16 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 21 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 21 May 2024 — PUBLISHED FOR OPPOSITION

View this trademark record on Marksy